[ CAS No. 38675-10-4 ] {[proInfo.proName]}

Name: 38675-10-4|Boc-D-PHE-PRO-OH|98%
Brand: Ambeed
SKU: A929190
Price: 13.0 USD
Availability: InStock
Rating: 90 (22 reviews)

,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

2D 3D

Structure of 38675-10-4 * Storage: {[proInfo.prStorage]}

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 110K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 38675-10-4 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 38675-10-4 ]

SDS Specification

Alternatived Products of [ 38675-10-4 ]

Product Details of [ 38675-10-4 ]

CAS No. :	38675-10-4	MDL No. :	MFCD00237546
Formula :	C₁₉H₂₆N₂O₅	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	ZPRHVPHDENDZTP-CABCVRRESA-N
M.W :	362.42	Pubchem ID :	1797945
Synonyms :

Calculated chemistry of [ 38675-10-4 ]

Physicochemical Properties

Num. heavy atoms :	26
Num. arom. heavy atoms :	6
Fraction Csp3 :	0.53
Num. rotatable bonds :	9
Num. H-bond acceptors :	5.0
Num. H-bond donors :	2.0
Molar Refractivity :	100.27
TPSA :	95.94 Å²

Pharmacokinetics

GI absorption :	High
BBB permeant :	No
P-gp substrate :	Yes
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-6.69 cm/s

Lipophilicity

Log Po/w (iLOGP) :	2.35
Log Po/w (XLOGP3) :	2.56
Log Po/w (WLOGP) :	1.82
Log Po/w (MLOGP) :	1.5
Log Po/w (SILICOS-IT) :	1.66
Consensus Log Po/w :	1.98

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	0.0
Bioavailability Score :	0.56

Water Solubility

Log S (ESOL) :	-3.28
Solubility :	0.192 mg/ml ; 0.000529 mol/l
Class :	Soluble
Log S (Ali) :	-4.22
Solubility :	0.0217 mg/ml ; 0.0000599 mol/l
Class :	Moderately soluble
Log S (SILICOS-IT) :	-3.29
Solubility :	0.185 mg/ml ; 0.000512 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	2.0
Synthetic accessibility :	3.5

Safety of [ 38675-10-4 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 38675-10-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Downstream synthetic route of [ 38675-10-4 ]

[ 38675-10-4 ] Synthesis Path-Downstream 1~88

1
[ 38675-10-4 ]
diphenyl 1-amino-2-(4-cyanophenyl)ethanephosphonate hydrobromide [ No CAS ]
diphenyl 1-<<N-(tert-butyloxycarbonyl)-D-phenylalanyl-L-prolyl>amino>-2-(4-cyanophenyl)ethanephosphonate [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,1994,vol. 37,p. 226 - 231

2
[ 38675-10-4 ]
diphenyl 1-amino-2-(4-amidinophenyl)ethanephosphonate dihydrochloride [ No CAS ]
[ 198902-77-1 ]

Reference： [1]Journal of Medicinal Chemistry,1994,vol. 37,p. 226 - 231

3
[ 64471-88-1 ]
[ 38675-10-4 ]

Reference： [1]Journal of Medicinal Chemistry,1994,vol. 37,p. 226 - 231
[2]Journal of Medicinal Chemistry,2010,vol. 53,p. 2126 - 2135
[3]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49
[4]Journal of Medicinal Chemistry,2005,vol. 48,p. 1984 - 2008

4
[ 38675-10-4 ]
[ 70-11-1 ]
[ 139740-97-9 ]

Reference： [1]Bulletin of the Chemical Society of Japan,1992,vol. 65,p. 228 - 233

5
[ 38675-10-4 ]
[ 543-27-1 ]
C₂₄H₃₄N₂O₇ [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,1990,vol. 33,p. 394 - 407

6
[ 38675-10-4 ]
[4-((1S,2R)-1-Amino-2-hydroxy-2-methylcarbamoyl-ethyl)-cyclohexyl]-carbamic acid tert-butyl ester [ No CAS ]
{4-[1-({(S)-1-[(R)-2-(tert-Butoxycarbonyl-methyl-amino)-3-phenyl-propionyl]-pyrrolidine-2-carbonyl}-amino)-2-hydroxy-2-methylcarbamoyl-ethyl]-cyclohexyl}-carbamic acid tert-butyl ester [ No CAS ]

Reference： [1]Tetrahedron Letters,1996,vol. 37,p. 5045 - 5048

7
[ 38675-10-4 ]
4‐(2‐aminoethyl)benzonitrile hydrochloride [ No CAS ]
[ 183595-83-7 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,1996,vol. 6,p. 2387 - 2392

8
[ 38675-10-4 ]
3-(2-aminoethyl)benzonitrile hydrochloride [ No CAS ]
((R)-1-Benzyl-2-{(S)-2-[2-(3-cyano-phenyl)-ethylcarbamoyl]-pyrrolidin-1-yl}-2-oxo-ethyl)-carbamic acid tert-butyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,1996,vol. 6,p. 2387 - 2392

9
[ 38675-10-4 ]
3-Aminomethyl-benzonitrile; compound with trifluoro-acetic acid [ No CAS ]
{(R)-1-Benzyl-2-[(S)-2-(3-cyano-benzylcarbamoyl)-pyrrolidin-1-yl]-2-oxo-ethyl}-carbamic acid tert-butyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,1996,vol. 6,p. 2387 - 2392

10
[ 38675-10-4 ]
4-(aminomethyl)benzonitrile trifluoroacetate salt [ No CAS ]
[ 172348-68-4 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,1996,vol. 6,p. 2387 - 2392

11
[ 38675-10-4 ]
2-[(2-amino-6-benzyloxycarbonylamino-hexyl)-tert-butoxycarbonyl-amino]-thiazole-4-carboxylic acid ethyl ester [ No CAS ]
2-[(6-benzyloxycarbonylamino-2-[1-(2-tert-butoxycarbonylamino-3-phenyl-propionyl)-pyrrolidine-2-carbonyl]-amino}-hexyl)-tert-butoxycarbonyl-amino]-thiazole-4-carboxylic acid ethyl ester [ No CAS ]

Reference： [1]Synlett,1999,p. 1239 - 1240

12
[ 38675-10-4 ]
[ 2450-71-7 ]
N-Boc-D-Phe-Pro-NHCH₂CCH [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 2775 - 2778

13
[ 5036-48-6 ]
[ 38675-10-4 ]
{(R)-1-Benzyl-2-[(S)-2-(3-imidazol-1-yl-propylcarbamoyl)-pyrrolidin-1-yl]-2-oxo-ethyl}-carbamic acid tert-butyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

14
[ 38675-10-4 ]
[ 108468-00-4 ]
[ 172348-61-7 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49
[2]Journal of Medicinal Chemistry,2021,vol. 64,p. 1611 - 1625

15
[ 38675-10-4 ]
[ 128009-23-4 ]
C₃₄H₅₄N₆O₈ [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

16
[ 38675-10-4 ]
[ 162167-83-1 ]
[ 162167-93-3 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

17
[ 38675-10-4 ]
[ 185744-62-1 ]
[ 185744-63-2 ]

Reference： [1]Journal of Medicinal Chemistry,2002,vol. 45,p. 4419 - 4432

18
[ 38675-10-4 ]
[ 740067-13-4 ]
[ 474081-24-8 ]

Reference： [1]Journal of Medicinal Chemistry,2002,vol. 45,p. 4419 - 4432

19
[ 38675-10-4 ]
H-Lys(Cbz)-(2-thiazolyl)*TFA [ No CAS ]
Boc-D-Phe-Pro-Lys(Cbz)-(2-thiazolyl) [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2002,vol. 45,p. 4419 - 4432

20
[ 38675-10-4 ]
C₂₃H₃₃N₅O₄S₂*C₂HF₃O₂ [ No CAS ]
C₄₂H₅₇N₇O₈S₂ [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2002,vol. 45,p. 4419 - 4432

21
[ 38675-10-4 ]
[ 449756-94-9 ]
[ 449758-33-2 ]

Reference： [1]Journal of Medicinal Chemistry,2004,vol. 47,p. 2995 - 3008

22
[ 38675-10-4 ]
[ 449756-97-2 ]
[ 724710-05-8 ]

Reference： [1]Journal of Medicinal Chemistry,2004,vol. 47,p. 2995 - 3008

23
[ 38675-10-4 ]
[ 449756-95-0 ]
{(R)-1-Benzyl-2-[(S)-2-(5-chloro-2-tetrazol-1-yl-benzylcarbamoyl)-pyrrolidin-1-yl]-2-oxo-ethyl}-carbamic acid tert-butyl ester [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2004,vol. 47,p. 2995 - 3008

24
[ 38675-10-4 ]
[ 404922-72-1 ]
{(R)-1-Benzyl-2-[(S)-2-(5-chloro-2-[1,2,4]triazol-1-yl-benzylcarbamoyl)-pyrrolidin-1-yl]-2-oxo-ethyl}-carbamic acid tert-butyl ester [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2004,vol. 47,p. 2995 - 3008

25
[ 38675-10-4 ]
[ 594-44-5 ]
[ 172348-40-2 ]

Reference： [1]Journal of Medicinal Chemistry,2005,vol. 48,p. 1984 - 2008

26
[ 18942-49-9 ]
Fmoc-D-Trp(Boc)-OHFmoc-Val-OH [ No CAS ]
[ 38675-10-4 ]

Reference： [1]Journal of Medicinal Chemistry,2005,vol. 48,p. 1984 - 2008

27
[ 38675-10-4 ]
N-(ethylsulfonyl)-D-phenylalanyl-N-[1-(trans-4-aminocyclohexyl)-2-(2-benzothiazolyl)-2-oxoethyl]-L-prolinamide [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2005,vol. 48,p. 1984 - 2008

28
[ 38675-10-4 ]
N-(ethylsulfonyl)-D-phenylalanyl-N-[4-[(aminoiminomethyl)amino]-1-(2-benzothiazolylcarbonyl)butyl]-L-prolinamide [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2005,vol. 48,p. 1984 - 2008

29
[ 38675-10-4 ]
C₄₁H₅₁N₇O₉S₃ [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2005,vol. 48,p. 1984 - 2008

30
[ 38675-10-4 ]
C₄₁H₅₃N₇O₉S₃ [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2005,vol. 48,p. 1984 - 2008

31
[ 38675-10-4 ]
C₄₆H₆₁N₅O₁₀S₃ [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2005,vol. 48,p. 1984 - 2008

32
[ 38675-10-4 ]
C₄₆H₅₉N₅O₁₀S₃ [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2005,vol. 48,p. 1984 - 2008

33
[ 16652-71-4 ]
[ 38675-10-4 ]

Reference： [1]Journal of Medicinal Chemistry,2005,vol. 48,p. 1984 - 2008

34
[ 38675-10-4 ]
(S)-1-((R)-2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid 2-[1,2,4]triazol-1-yl-benzylamide [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2004,vol. 47,p. 2995 - 3008

35
[ 38675-10-4 ]
(S)-1-((R)-2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid 2-tetrazol-1-yl-benzylamide [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2004,vol. 47,p. 2995 - 3008

36
[ 38675-10-4 ]
(S)-1-((R)-2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid 5-chloro-2-tetrazol-1-yl-benzylamide [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2004,vol. 47,p. 2995 - 3008

37
[ 18942-49-9 ]
[ 38675-10-4 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49
[2]Journal of Medicinal Chemistry,1994,vol. 37,p. 226 - 231
[3]Journal of Medicinal Chemistry,1993,vol. 36,p. 314 - 319
[4]Journal of Medicinal Chemistry,2016,vol. 59,p. 7576 - 7583
[5]Patent: WO2017/21004,2017,A1
[6]Cell Chemical Biology,2021,vol. 28,p. 221 - 7,227

38
[ 38675-10-4 ]
[ 80079-63-6 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

39
[ 38675-10-4 ]
(S)-1-((R)-2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid (3-imidazol-1-yl-propyl)-amide [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

40
[ 38675-10-4 ]
[ 787525-83-1 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

41
[ 38675-10-4 ]
(S)-1-((R)-2-Methanesulfonylamino-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid (3-imidazol-1-yl-propyl)-amide [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

42
[ 38675-10-4 ]
(S)-1-((R)-2-Methanesulfonylamino-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid 4-aminomethyl-benzylamide [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

43
[ 38675-10-4 ]
[ 162167-84-2 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

44
[ 38675-10-4 ]
(S)-1-((R)-2-Acetylamino-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid (4-guanidino-butyl)-amide [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

45
[ 38675-10-4 ]
(S)-1-((R)-2-Methanesulfonylamino-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid (4-guanidino-butyl)-amide [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

46
[ 38675-10-4 ]
BMS-189664 [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

47
[ 38675-10-4 ]
(S)-1-((R)-3-Phenyl-2-trifluoromethanesulfonylamino-propionyl)-pyrrolidine-2-carboxylic acid (4-guanidino-butyl)-amide [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

48
[ 38675-10-4 ]
{(R)-1-Benzyl-2-[(S)-2-(4-guanidino-butylcarbamoyl)-pyrrolidin-1-yl]-2-oxo-ethyl}-carbamic acid benzyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

49
[ 38675-10-4 ]
(S)-1-((R)-3-Phenyl-2-phenylmethanesulfonylamino-propionyl)-pyrrolidine-2-carboxylic acid (1-carbamimidoyl-piperidin-4-ylmethyl)-amide [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

50
[ 38675-10-4 ]
(S)-1-[(R)-2-(Naphthalene-2-sulfonylamino)-3-phenyl-propionyl]-pyrrolidine-2-carboxylic acid (4-guanidino-butyl)-amide [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

51
[ 38675-10-4 ]
(S)-1-[(S)-2-(Naphthalene-2-sulfonylamino)-3-phenyl-propionyl]-pyrrolidine-2-carboxylic acid (4-guanidino-butyl)-amide [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49

52
[ 41324-66-7 ]
[ 38675-10-4 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2002,vol. 12,p. 45 - 49
[2]Journal of Medicinal Chemistry,1994,vol. 37,p. 226 - 231

53
[ 38675-10-4 ]
{(R)-1-Benzyl-2-oxo-2-[(S)-2-(3-pyridin-4-yl-prop-2-ynylcarbamoyl)-pyrrolidin-1-yl]-ethyl}-carbamic acid tert-butyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 2775 - 2778

54
[ 38675-10-4 ]
(1-benzyl-2-oxo-2-{2-[3-(1H-pyrazol-4-yl)-prop-2-ynylcarbamoyl]-pyrrolidin-1-yl}-ethyl)-carbamic acid tert-butyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 2775 - 2778

55
[ 38675-10-4 ]
(1-benzyl-2-{2-[3-(1H-imidazol-4-yl)-prop-2-ynylcarbamoyl]-pyrrolidin-1-yl}-2-oxo-ethyl)-carbamic acid tert-butyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 2775 - 2778

56
[ 38675-10-4 ]
(1-benzyl-2-{2-[3-(3-methyl-3H-imidazol-4-yl)-prop-2-ynylcarbamoyl]-pyrrolidin-1-yl}-2-oxo-ethyl)-carbamic acid tert-butyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 2775 - 2778

57
[ 38675-10-4 ]
((R)-2-{(S)-2-[3-(6-Amino-pyridin-3-yl)-prop-2-ynylcarbamoyl]-pyrrolidin-1-yl}-1-benzyl-2-oxo-ethyl)-carbamic acid tert-butyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 2775 - 2778

58
[ 38675-10-4 ]
(1-benzyl-2-oxo-2-{2-[3-(1-trityl-1H-imidazol-4-yl)-prop-2-ynylcarbamoyl]-pyrrolidin-1-yl}-ethyl)-carbamic acid tert-butyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 2775 - 2778

59
[ 38675-10-4 ]
(S)-1-((R)-2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid [2-(3-carbamimidoyl-phenyl)-ethyl]-amide; hydrochloride [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,1996,vol. 6,p. 2387 - 2392

60
[ 38675-10-4 ]
(S)-1-((R)-2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid [2-(4-carbamimidoyl-phenyl)-ethyl]-amide; hydrochloride [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,1996,vol. 6,p. 2387 - 2392

61
[ 38675-10-4 ]
(S)-1-((R)-2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid 3-carbamimidoyl-benzylamide; compound with trifluoro-acetic acid [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,1996,vol. 6,p. 2387 - 2392

62
[ 38675-10-4 ]
(S)-1-((R)-2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid 4-carbamimidoyl-benzylamide; compound with trifluoro-acetic acid [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,1996,vol. 6,p. 2387 - 2392

63
[ 38675-10-4 ]
diphenyl 1-<N-(D-phenylalanyl-L-prolyl)amino>-2-(4-amidinophenyl)ethanephosphonate dihydrochloride [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,1994,vol. 37,p. 226 - 231

64
[ 38675-10-4 ]
C₃₃H₄₄N₆O₇ [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,1993,vol. 36,p. 314 - 319

65
[ 38675-10-4 ]
Boc-D-Phe-Pro-Arg-H*2HOAc [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,1993,vol. 36,p. 314 - 319

66
[ 38675-10-4 ]
[ 139741-08-5 ]

Reference： [1]Bulletin of the Chemical Society of Japan,1992,vol. 65,p. 228 - 233

67
[ 38675-10-4 ]
[ 139740-98-0 ]

Reference： [1]Bulletin of the Chemical Society of Japan,1992,vol. 65,p. 228 - 233

68
[ 38675-10-4 ]
[ 139740-99-1 ]

Reference： [1]Bulletin of the Chemical Society of Japan,1992,vol. 65,p. 228 - 233

69
[ 38675-10-4 ]
[ 139741-01-8 ]

Reference： [1]Bulletin of the Chemical Society of Japan,1992,vol. 65,p. 228 - 233

70
[ 38675-10-4 ]
[ 751450-50-7 ]

Reference： [1]Bulletin of the Chemical Society of Japan,1992,vol. 65,p. 228 - 233

71
[ 38675-10-4 ]
[ 139741-00-7 ]

Reference： [1]Bulletin of the Chemical Society of Japan,1992,vol. 65,p. 228 - 233

72
[ 38675-10-4 ]
[ 123239-02-1 ]

Reference： [1]Journal of Medicinal Chemistry,1990,vol. 33,p. 394 - 407

73
[ 38675-10-4 ]
N-<(1,1-dimethylethoxy)carbonyl>-D-phenylalanyl-N-<3,3,3-trifluoro-1-(1-methylethyl)-2-oxopropyl>-L-prolinamide [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,1990,vol. 33,p. 394 - 407

74
[ 38675-10-4 ]
N-(4-methoxy-1,4-dioxobutyl)-D-phenylalanyl-N-<3,3,3-trifluoro-1-(1-methylethyl)-2-oxopropyl>-L-prolinamide [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,1990,vol. 33,p. 394 - 407

75
[ 38675-10-4 ]
D-phenylalanyl-N-<3,3,3-trifluoro-1-(1-methylethyl)-2-oxopropyl>-L-prolinamide hydrochloride [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,1990,vol. 33,p. 394 - 407

76
[ 38675-10-4 ]
[ 439116-15-1 ]
N-(tert-butoxyacetyl)-D-phenylalanyl-N-(2-[(tert-butoxycarbonyl)amino]methyl}-5-chlorobenzyl)-L-prolinamide [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	With 1,2-dichloro-ethane; In N-methyl-acetamide;	Step A N-(tert-butoxyacetyl)-D-phenylalanyl-N-(2-[(tert-butoxycarbonyl)amino]methyl}-5-chlorobenzyl)-L-prolinamide To a solution of tert-Butyl 2-(aminomethyl)-4-chlorobenzylcarbamate (0.14 mmol, 37 mg), EDC (0.21 mmol, 40 mg), and <strong>[38675-10-4]Boc-D-Phe-Pro-OH</strong> (0.14 mmol, 50 mg), in 0.5 mL dimethylformamide, was added HOAT (0.15 mmol, 21 mg). The solution was stirred overnight and purified by prep HPLC to give N-(tert-Butoxyacetyl)-D-phenylalanyl-N-(2-{(tert-butoxycarbonyl)amino]methyl}-5-chlorobenzyl)-L-prolinamide. Mass Spec ES (M+1)=615.2.

Reference： [1]Patent: US2002/119992,2002,A1

77
[ 71760-04-8 ]
[ 38675-10-4 ]
[ 86225-78-7 ]
[ 182159-22-4 ]

Yield	Reaction Conditions	Operation in experiment
	With diisopropylamine; In dichloromethane; ethyl acetate;	(c) Boc-D-phenylalanyl-proline (D,L)-α-methyl-4-cyanobenzylamide 16.2 g of diisopropylamine and 22 ml (30 mmol) of propanephosphonic anhydride (50% strength solution in ethyl acetate) were added dropwise to a solution of 3.65 g (25 mmol) of 1-(4-cyanophenyl)ethylamine and 9.1 g (25 mmol) of <strong>[38675-10-4]Boc-D-Phe-Pro-OH</strong> in 150 ml of methylene chloride at -50 C. The mixture was stirred for 2 h, during which the temperature was allowed to rise from -5 to 20 C. The organic phase was washed with water, 5% strength sodium bicarbonate and 5% strength citric acid solutions, dried over Na2SO4 and evaporated to dryness. A pale yellowish crystalline residue was obtained and was used without further purification in the next reaction.

Reference： [1]Patent: US6455671,2002,B1

78
[ 71760-04-8 ]
[ 38675-10-4 ]
[ 181130-14-3 ]
[ 181130-15-4 ]

Yield	Reaction Conditions	Operation in experiment
	With N-ethyl-N,N-diisopropylamine; In dichloromethane; ethyl acetate;	c) Boc-D-phenylalanylproline (6-cyano-3-picolyl)amide 8.12 g of diisopropylethylamine and subsequently 11 ml (15 mmol) of propanephosphonic anhydride (50% strength solution in ethyl acetate) were added dropwise to a solution of 2.11 g (12.5 mmol) of 2-cyano-5-(aminomethyl)pyridine and 4.5 g (12.5 mmol) of <strong>[38675-10-4]Boc-D-Phe-Pro-OH</strong> in 70 ml of CH2Cl2 at -5 C. The mixture was then stirred for 2 h, during which the temperature was allowed to rise from -5 to 20 C. The organic phase was washed with water, 5% strength sodium bicarbonate and 5% strength citric acid solutions, dried over Na2SO4 and evaporated to dryness. A pale yellowish crystalline residue was obtained, melting point 167-170 C., and was used without further purification in the next reaction.

Reference： [1]Patent: US6455671,2002,B1

79
[ 71760-04-8 ]
[ 38675-10-4 ]
[ 86225-78-7 ]
Boc-(D)-phenylalanylproline (α-methyl-4-cyano)benzylamide [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	With diisopropylamine; In dichloromethane; ethyl acetate;	(c) Boc-(D)-phenylalanylproline (α-methyl-4-cyano)benzylamide 16.2 g of diisopropylamine and 22 ml (30 mmol) of propanephosphonic anhydride (50% strength solution in ethyl acetate) were added dropwise to a solution of 3.65 g (25 mmol) of 1-(4-cyanophenyl)ethylamine and 9.1 g (25 mmol) of <strong>[38675-10-4]Boc-D-Phe-Pro-OH</strong> in 150 ml of methylene chloride at -5 C. The mixture was then stirred for 2 h, during which the temperature was allowed to rise from -5 to 20 C. The organic phase was washed with water, 5%. strength sodium bicarbonate solution and 5% strength citric acid solution, dried over Na2 SO4 and evaporated to dryness. A pale yellowish crystalline residue was obtained and was used without further purification in the next reaction.

Reference： [1]Patent: US5932567,1999,A

80
[ 71760-04-8 ]
[ 38675-10-4 ]
[ 181130-14-3 ]
Boc-(D)-phenylalanylproline (6-cyano)-3-picolylamide [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	With N-ethyl-N,N-diisopropylamine; In dichloromethane; ethyl acetate;	c Boc-(D)-phenylalanylproline (6-cyano)-3-picolylamide 8.12 g of diisopropylethylamine, and subsequently 11 ml (15 mmol) of propanephosphonic anhydride (50% strength solution in ethyl acetate), were added dropwise to a solution of 2.11 g (12.5 mmol) of 2-cyano-5-(aminomethyl)pyridine and 4.5 g (12.5 mmol) of <strong>[38675-10-4]Boc-D-Phe-Pro-OH</strong> in 70 ml of CH2 Cl2 at -5 C. The mixture was then stirred for 2 h, allowing the temperature to rise from -5 to 20 C. The organic phase was washed with water, 5% strength sodium bicarbonate and 5% strength citric acid solutions, dried over Na2 SO4 and evaporated to dryness, a pale yellowish crystalline residue was obtained, melting point 167-170 C., which was used in the next reaction without further purification.

Reference： [1]Patent: US5932567,1999,A

81
[ 10406-25-4 ]
[ 38675-10-4 ]
[ 543-27-1 ]
[ 172348-68-4 ]

Yield	Reaction Conditions	Operation in experiment
	With 4-methyl-morpholine; In hexane; water; ethyl acetate; N,N-dimethyl-formamide;	a Boc-D-Phenylalanylproline (p-cyanobenzyl)amide 2.0 g (14.6 mmol) of isobutyl chloroformate were added in 2 min to a solution of 5.1 g (14.2 mmol) of <strong>[38675-10-4]Boc-D-Phe-Pro-OH</strong> and 1.53 g (15.2 mmol) of N-methylmorpholine in 15 ml of DMF at -15 C., the mixture was stirred for 10 min and then a solution of 1.9 g (14.2 mmol) of p-cyanobenzylamine (W. Walter et al., Ann. 660, 1962, 60) and 1.53 g of N-methylmorpholine in 3 ml of DMF was added. After stirring at -15 C. for 3 h, a TLC check (CH2 Cl2 /MeOH, 9/1) showed no detectable starting compounds. For isolation, the reaction mixture was poured into 200 ml of water, when an oil separated out and, after a short time, solidifed and was broken up and filtered off with suction. The still moist residue was dissolved in a mixture of 250 ml of ethyl acetate and 50 ml of ether and washed successively with a 5% strength aqueous citric acid, bicarbonate and saturated sodium chloride solutions. After drying over Na2 SO4, the solvent was removed by distillation under reduced pressure, and the residue was mixed with n-hexane and then filtered off with suction. Recrystallization from 50 ml of ethyl acetate afforded 5.6 g of TLC-pure product, m.p. 156-157 C.

Reference： [1]Patent: US5852051,1998,A

82
[ 38675-10-4 ]
[ 106006-81-9 ]
tert-Butyl (1R)-2-((2S)-2-[(2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl)amino]carbonyl}pyrrolidinyl)-1-benzyl-2-oxoethylcarbamate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
64%	With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In N,N-dimethyl-formamide;pH 8.0;	To the solution of <strong>[38675-10-4]Boc-D-Phe-L-Pro-OH</strong> (580 mg, 1.60 mmol) and 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine dihydrobromide (482 mg, 1.46 mmol) in 3.7 mL of N,N-dimethylformamide was added HOBt (247 mg, 1.60 mmol). N-Methylmorpholine was used to set pH of the solution to 8 and EDC (313 mg, 1.60 mmol) was added. The reaction mixture was stirred overnight, the solvent was evaporated in vacuo and the residue partitioned between EtOAc and saturated solution of NaHCO3. Organic layer was washed with brine dried with MgSO4, filtered and the solvent was evaporated under reduced pressure. The crude product was purified with column chromatography (silicagel, CHCl3/MeOH=9/1) to yield 480 mg of faint brown crystalline solid (64%). Melting point: 120-123 C. IR (KBr): ν=3418, 2975, 1646, 1523, 1448, 1367, 1252, 1167, 860, 752, 702 cm-1. MS (FAB): m/z (%) 514 (MH+, 59/2.50), 70 (100).

Reference： [1]Patent: US2003/191139,2003,A1 .Location in patent: Page/Page column 18

83
[ 38675-10-4 ]
N'-benzyloxycarbonyl-4-aminomethylbenzamidine hydrochloride [ No CAS ]
[ 1189747-88-3 ]

Reference： [1]Journal of Medicinal Chemistry,2010,vol. 53,p. 2126 - 2135

84
[ 126251-09-0 ]
[ 38675-10-4 ]

Reference： [1]Cell Chemical Biology,2021,vol. 28,p. 221 - 7,227
[2]Journal of Medicinal Chemistry,2016,vol. 59,p. 7576 - 7583
[3]Patent: WO2017/21004,2017,A1 .Location in patent: Page/Page column 15; 20
[4]Journal of Medicinal Chemistry,2011,vol. 54,p. 2022 - 2028
[5]Synlett,2011,p. 797 - 800

85
Arg-PAB-resorufin*2TFA [ No CAS ]
[ 38675-10-4 ]
C₄₄H₅₀N₈O₈ [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2016,vol. 59,p. 7576 - 7583

86
[ 38675-10-4 ]
(12S,11R)-11-benzyl-3,7,10-triaza-1(2,1)-pyrrolidina-6(1,3)-benzenacyclododecaphane-2,9,12-trione trifluoroacetic acid [ No CAS ]

Reference： [1]Organic Letters,2016,vol. 18,p. 4072 - 4075

87
[ 38675-10-4 ]
2-(((R)-1-((S)-2-((3-bromophenethyl)carbamoyl)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)amino)-2-oxoethan-1-aminium chloride [ No CAS ]

Reference： [1]Organic Letters,2016,vol. 18,p. 4072 - 4075

88
[ 38675-10-4 ]
C₂₂H₂₆BrN₃O₂*ClH [ No CAS ]

Reference： [1]Organic Letters,2016,vol. 18,p. 4072 - 4075

Same Skeleton Products

Related Products

Historical Records

Related Functional Groups of
[ 38675-10-4 ]

Amino Acid

[ 13122-90-2 ]

Boc-Phe-Phe-OH

Similarity: 0.95

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Purity	Size	Price	VIP Price	USA Stock *0-1 Day	Global Stock *5-7 Days	Quantity
{[ item.p_purity ]}	{[ item.pr_size ]}	{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]}	{[ getRatePrice(item.pr_usd, 1,1) ]}	Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]}	{[ item.pr_usastock ]}	Inquiry -	{[ item.pr_chinastock ]}	Inquiry -

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

[ CAS No. 38675-10-4 ] {[proInfo.proName]}

Quality Control of [ 38675-10-4 ]

Related Doc. of [ 38675-10-4 ]

Product Details of [ 38675-10-4 ]

Calculated chemistry of [ 38675-10-4 ]

Physicochemical Properties

Pharmacokinetics

Lipophilicity

Druglikeness

Water Solubility

Medicinal Chemistry

Safety of [ 38675-10-4 ]

Application In Synthesis of [ 38675-10-4 ]

[ 38675-10-4 ] Synthesis Path-Downstream 1~88

Related Functional Groups of [ 38675-10-4 ]

Amino Acid

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Related Functional Groups of
[ 38675-10-4 ]